Original Research
Accepted on 30 Dec 2025
Dual Inhibition of ERG11 and CDR2 in Drug-Resistant Candida albicans by Indian Phytochemicals: A Combined In Silico–In Vitro Aproach
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
Type at least 3 characters
439 articles
articles
Original Research
Accepted on 30 Dec 2025
Serum valeric acid stimulates lung epithelial cilia assembly and improves prognosis in patients with severe respiratory infections
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
Original Research
Accepted on 25 Dec 2025
Chronic Statin Therapy and Sepsis Outcomes: Insights from a Population-Based Cohort of 59,578 Hospitalised Patients
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
Systematic Review
Accepted on 24 Dec 2025
Population pharmacokinetics of imipenem in different populations for individualized dosing: A systematic review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
Study Protocol
Published on 19 Dec 2025
Rifapentine- and moxifloxacin-containing short-course regimens for mild spinal tuberculosis: study protocol for a multicenter, randomized, non-inferiority phase II clinical trial
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1684771
- 524 views
Original Research
Published on 18 Dec 2025
Bromhexine hydrochloride enhances the therapeutic efficacy of tiamulin against experimental Staphylococcus aureus infection in dogs: targeting bacterial virulence, boosting antioxidant defense, and improving histopathology
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1679854
- 575 views
Policy and Practice Reviews
Published on 18 Dec 2025
Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1713471
- 1,196 views
Original Research
Accepted on 15 Dec 2025
Study on the correlation between plasma concentration of voriconazole and clinical efficacy and safety in elderly patients
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
- 167 views
Original Research
Accepted on 15 Dec 2025
Antibiotic use for respiratory tract infections in nursing homes: a multicentre cross-sectional study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
Original Research
Accepted on 15 Dec 2025
Molecular features of prenylated (iso)flavonoids from Fabaceae in relation to their potential NorA inhibition in Staphylococcus aureus
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
Original Research
Accepted on 02 Dec 2025
Activity-Based Chemoproteomic Profiling Reveals the Active Kinome of Leishmania
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
- 182 views
Original Research
Published on 02 Dec 2025
Branched tetrameric lactoferricin peptides modified with diaminopropionic acid exhibit potent antimicrobial and wound-healing activities
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1719557
- 861 views
Review
Published on 21 Nov 2025
Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1685710
- 1,111 views
Review
Published on 20 Nov 2025
Design and synthesis of natural antibacterial derivatives for ocular tuberculosis: a comprehensive review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1697986
- 1,091 views
Original Research
Published on 18 Nov 2025
Efficacy and safety of omadacycline for the treatment of infectious diseases: a real-world, retrospective study of 2587 patients
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1706601
- 1,067 views
Review
Published on 13 Nov 2025
Myasthenia gravis and community-acquired pneumonia: therapeutic challenges
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1695526
- 1,413 views
Review
Published on 12 Nov 2025
Polyphenolic compounds in combating MDR periodontal pathogens: current research and future directions
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1678979
- 1,354 views
Original Research
Published on 12 Nov 2025
Tigecycline pharmacodynamics in the hollow fiber system of Mycobacterium avium-complex lung disease and the utility of MICs and time-kill studies in drug development
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1682477
- 712 views
Original Research
Published on 10 Nov 2025
A novel drug that reduces pneumococcal toxicity by targeting pneumolysin (PLY): efficacy of the traditional Chinese medicine Radix Paeoniae Alba
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1609457
- 895 views
Systematic Review
Published on 06 Nov 2025
Association between point mutations of macrolide-resistant Mycoplasma pneumoniae and clinical antibiotic treatment efficacy: a meta-analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1682167
- 1,120 views
Original Research
Published on 29 Oct 2025
Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654173
- 1,706 views
Systematic Review
Published on 29 Oct 2025
Factors affecting the effectiveness and safety of colistin in treating drug-resistant gram-negative bacterial infections: a meta-analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1625595
- 1,342 views
Original Research
Published on 27 Oct 2025
Comparative in vitro susceptibility of clinical Leishmania isolates to miltefosine and oleylphosphocholine
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1688856
- 1,386 views
Original Research
Published on 27 Oct 2025
Synthetic bakuchiol derivatives: ester and ether analogs with activity against clinically important bacteria
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1619997
- 1,137 views